These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11751767)

  • 21. The association between occurrence of plasmid-mediated quinolone resistance and ciprofloxacin resistance in Escherichia coli isolates of different origins.
    Yang T; Zeng Z; Rao L; Chen X; He D; Lv L; Wang J; Zeng L; Feng M; Liu JH
    Vet Microbiol; 2014 May; 170(1-2):89-96. PubMed ID: 24553411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Investigation of plasmid-mediated quinolone resistance in Escherichia coli strains].
    Aktepe OC; Aşık G; Cetinkol Y; Biçmen M; Gülay Z
    Mikrobiyol Bul; 2012 Jan; 46(1):9-16. PubMed ID: 22399166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Chromosomal DNA Fragmentation by Quinolones in an Isogenic Collection of Escherichia coli with Defined Resistance Mechanisms.
    Rodríguez-Martínez JM; Santiso R; Machuca J; Bou G; Pascual Á; Fernández JL
    Microb Drug Resist; 2016 Jul; 22(5):354-9. PubMed ID: 26890225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates.
    Lin CY; Huang SH; Chen TC; Lu PL; Lin WR; Chen YH
    J Microbiol Immunol Infect; 2008 Aug; 41(4):325-31. PubMed ID: 18787740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of the plasmid-mediated quinolone resistance gene qnrS1 in Escherichia coli isolates in Greece.
    Vasilaki O; Ntokou E; Ikonomidis A; Sofianou D; Frantzidou F; Alexiou-Daniel S; Maniatis AN; Pournaras S
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2996-7. PubMed ID: 18490503
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasmid-Mediated Colistin Resistance Gene mcr-1 in an Escherichia coli ST10 Bloodstream Isolate in the Sultanate of Oman.
    Mohsin J; Pál T; Petersen JE; Darwish D; Ghazawi A; Ashraf T; Sonnevend A
    Microb Drug Resist; 2018 Apr; 24(3):278-282. PubMed ID: 28799833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Prevalence of Plasmid-Mediated Quinolone Resistance Determinants in Escherichia coli and Klebsiella pneumoniae Isolates from Pediatric Patients in China.
    Xue G; Li J; Feng Y; Xu W; Li S; Yan C; Zhao H; Sun H
    Microb Drug Resist; 2017 Jan; 23(1):107-114. PubMed ID: 27167505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing incidence of quinolone-resistant E. coli from urinary cultures in Ankara-Pursaklar region.
    Tekin O; Catal F; Ibýk B; Açýkgöz ZC
    Int J Antimicrob Agents; 2004 Apr; 23(4):416-7. PubMed ID: 15081097
    [No Abstract]   [Full Text] [Related]  

  • 29. Quinolone resistance in potentially pathogenic and non-pathogenic Escherichia coli strains isolated from healthy ruminants.
    Orden JA; Ruiz-Santa-Quiteria JA; Cid D; Díez R; Martínez S; de la Fuente R
    J Antimicrob Chemother; 2001 Sep; 48(3):421-4. PubMed ID: 11533010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetracycline use in the community may promote decreased susceptibility to quinolones in Escherichia coli isolates.
    Batard E; Vibet MA; Thibaut S; Corvec S; Pivette J; Lepelletier D; Caillon J; Montassier E
    Eur J Clin Microbiol Infect Dis; 2018 Feb; 37(2):271-276. PubMed ID: 29076047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamics of quinolone resistance in fecal Escherichia coli of finishing pigs after ciprofloxacin administration.
    Huang K; Xu CW; Zeng B; Xia QQ; Zhang AY; Lei CW; Guan ZB; Cheng H; Wang HN
    J Vet Med Sci; 2014 Sep; 76(9):1213-8. PubMed ID: 24919413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance Pattern and Molecular Characterization of Enterotoxigenic Escherichia coli (ETEC) Strains Isolated in Bangladesh.
    Begum YA; Talukder KA; Azmi IJ; Shahnaij M; Sheikh A; Sharmin S; Svennerholm AM; Qadri F
    PLoS One; 2016; 11(7):e0157415. PubMed ID: 27428376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
    Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
    Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and risk factors for selection of quinolone-resistant Escherichia coli strains in fecal flora of patients receiving quinolone therapy.
    Yagci D; Yoruk F; Azap A; Memikoglu O
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1287-9. PubMed ID: 19064895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals.
    Zhao L; Zhang J; Zheng B; Wei Z; Shen P; Li S; Li L; Xiao Y
    J Clin Microbiol; 2015 Mar; 53(3):766-70. PubMed ID: 25520451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum beta-lactamases.
    Jones GL; Warren RE; Skidmore SJ; Davies VA; Gibreel T; Upton M
    J Antimicrob Chemother; 2008 Dec; 62(6):1245-51. PubMed ID: 18827034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and characteristics of quinolone resistance in Escherichia coli in veal calves.
    Hordijk J; Veldman K; Dierikx C; van Essen-Zandbergen A; Wagenaar JA; Mevius D
    Vet Microbiol; 2012 Apr; 156(1-2):136-42. PubMed ID: 22041448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro susceptibility of quinolone-resistant clinical isolates of Escherichia coli to fosfomycin trometamol.
    Ungheri D; Albini E; Belluco G
    J Chemother; 2002 Jun; 14(3):237-40. PubMed ID: 12120876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model.
    Lee YS; Han CH; Kang SH; Lee SJ; Kim SW; Shin OR; Sim YC; Lee SJ; Cho YH
    Int J Urol; 2005 Apr; 12(4):383-9. PubMed ID: 15948727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.